Regulation of esophageal gene expression and function by KLF5 and p53

KLF5 和 p53 对食管基因表达和功能的调节

基本信息

  • 批准号:
    9127223
  • 负责人:
  • 金额:
    $ 34.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-20 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The esophageal lining is regularly exposed to irritants such as alcohol, cigarette smoke, hot beverages, dietary nitroso-compounds, and refluxate of gastro-duodenal contents, and disorders of the esophagus are significant health problems in the U.S. and throughout the world. For example, gastroesophageal reflux disease (GERD) leads to 8.9 million U.S. clinic visits annually, and esophageal cancer is the 6th most common cause of cancer death worldwide. In esophageal epithelia, the key transcriptional regulator Kr�ppel-like factor 5 (KLF5) promotes normal proliferation and migration, as we have shown, and we recently identified a novel relationship between KLF5 and p53 in esophageal epithelial cells, whereby p53 acts as a "molecular switch" for KLF5. p53 mutation in primary human esophageal keratinocytes converts KLF5 from pro-proliferative to anti-proliferative, an effect mediated predominantly by p21Waf1/Cip1, and KLF5 transcriptionally activates the keratinocyte tumor suppressor NOTCH1 when p53 is mutant but not with wild-type p53. In additional Preliminary Data, we demonstrate that KLF5 suppresses p53 in esophageal keratinocytes and provide evidence for genome-wide coordinate regulation by KLF5 and p53. Our overarching hypothesis is that KLF5 and p53 orchestrate a broad transcriptional program in esophageal keratinocytes that controls proliferation, growth arrest, apoptosis, and transformation. To test this hypothesis, we will pursue the following interrelated Specific Aims: 1. We will delineate the mechanisms through which KLF5 regulates p53 levels and function~ 2. We will define the mechanism for KLF5 functional switching on p21Waf1/Cip1~ 3. We will identify common and exclusive targets of KLF5 in the context of wild-type and mutant p53~ and 4. We will determine the functional consequences of KLF5 loss and p53 mutation in vivo. These complementary approaches are supported by our robust Preliminary Data, both published and unpublished. Moreover, the PI is an experienced investigator who is an expert in the Kr�ppel-like factors (KLFs), transcriptional regulation, animal models of gastrointestinal diseases, and esophageal squamous cell biology, as demonstrated by recent, relevant corresponding-author publications in Cancer Research, PLoS One, Cell Cycle, and Neoplasia. In addition, the PI is supported by a superb research team, complemented by expert collaborators, and by the exceptional resources, facilities, and intellectual environment of the University of Pennsylvania and the NIH-funded Center for Molecular Studies in Digestive and Liver Diseases. Overall, the proposed studies will provide key insights into the transcriptional regulation of esophageal epithelial homeostasis and the molecular pathways that underlie esophageal diseases, both benign and malignant.
描述(由申请人提供):食道内膜经常暴露于刺激物,如酒精、香烟烟雾、热饮、膳食亚硝基化合物和胃-十二指肠内容物的反流,食道疾病在美国和全世界都是重要的健康问题。例如,胃食管反流病(GERD)每年导致890万美国诊所就诊,食管癌是全球第六大最常见的癌症死亡原因。在食管上皮中,关键的转录调节因子KLF5促进正常的增殖和迁移,正如我们所表明的那样,我们最近发现了KLF5和食管上皮细胞p53之间的新关系,其中p53作为KLF5的“分子开关”。原代人食管角化细胞中p53突变将KLF5从促增殖转化为抗增殖,这一作用主要由p21Waf1/Cip1介导,当p53突变而非野生型p53时,KLF5转录激活角化细胞肿瘤抑制因子NOTCH1。在其他初步数据中,我们证明了KLF5抑制食管角化细胞中的p53,并为KLF5和p53的全基因组协调调节提供了证据。我们的总体假设是KLF5和p53在食管角化细胞中协调广泛的转录程序,控制增殖、生长停滞、凋亡和转化。为了验证这一假设,我们将追求以下相关的具体目标:1。我们将描述

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONATHAN P KATZ其他文献

JONATHAN P KATZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONATHAN P KATZ', 18)}}的其他基金

Cytoprotective pathways in esophageal squamous epithelia
食管鳞状上皮的细胞保护途径
  • 批准号:
    10660394
  • 财政年份:
    2023
  • 资助金额:
    $ 34.8万
  • 项目类别:
Molecular Pathology and Imaging Core
分子病理学和成像核心
  • 批准号:
    9762894
  • 财政年份:
    2019
  • 资助金额:
    $ 34.8万
  • 项目类别:
KLF4 and WNT5A in esophageal epithelial differentiation and stratification
KLF4和WNT5A在食管上皮分化和分层中的作用
  • 批准号:
    9889959
  • 财政年份:
    2019
  • 资助金额:
    $ 34.8万
  • 项目类别:
KLF4 and WNT5A in esophageal epithelial differentiation and stratification
KLF4和WNT5A在食管上皮分化和分层中的作用
  • 批准号:
    10374840
  • 财政年份:
    2019
  • 资助金额:
    $ 34.8万
  • 项目类别:
Regulation of esophageal gene expression and function by KLF5 and p53
KLF5 和 p53 对食管基因表达和功能的调节
  • 批准号:
    8652150
  • 财政年份:
    2013
  • 资助金额:
    $ 34.8万
  • 项目类别:
Regulation of esophageal gene expression and function by KLF5 and p53
KLF5 和 p53 对食管基因表达和功能的调节
  • 批准号:
    8737255
  • 财政年份:
    2013
  • 资助金额:
    $ 34.8万
  • 项目类别:
Regulation of differentiation in esophageal epithelia
食管上皮分化的调节
  • 批准号:
    8011268
  • 财政年份:
    2010
  • 资助金额:
    $ 34.8万
  • 项目类别:
Regulation of differentiation in esophageal epithelia
食管上皮分化的调节
  • 批准号:
    7850318
  • 财政年份:
    2009
  • 资助金额:
    $ 34.8万
  • 项目类别:
The role of Klf5 in GI epithelial homeostasis and disease
Klf5 在胃肠道上皮稳态和疾病中的作用
  • 批准号:
    7812268
  • 财政年份:
    2009
  • 资助金额:
    $ 34.8万
  • 项目类别:
The role of KLF5 in GI epithelial homeostasis and disease
KLF5 在胃肠道上皮稳态和疾病中的作用
  • 批准号:
    7888558
  • 财政年份:
    2008
  • 资助金额:
    $ 34.8万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.8万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了